TransMedics Group Inc
Company Profile
Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USAT: +1 978 552-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2024
Employees
584
TransMedics Group Inc News & Analysis
funds
Lessons from running a fund for 10 years
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,484.10 | 33.20 | 0.39% |
| CAC 40 | 7,216.83 | 10.15 | -0.14% |
| DAX 40 | 19,003.11 | 30.53 | -0.16% |
| Dow JONES (US) | 43,958.19 | 47.21 | 0.11% |
| FTSE 100 | 8,030.33 | 4.56 | 0.06% |
| HKSE | 19,823.45 | 23.43 | -0.12% |
| NASDAQ | 19,230.72 | 50.68 | -0.26% |
| Nikkei 225 | 38,883.71 | 162.05 | 0.42% |
| NZX 50 Index | 12,651.87 | 22.62 | -0.18% |
| S&P 500 | 5,985.38 | 1.39 | 0.02% |
| S&P/ASX 200 | 8,230.80 | 37.40 | 0.46% |
| SSE Composite Index | 3,439.28 | 17.31 | 0.51% |